Small-Cap REIT ETF ...
Health Care: Drugs
Rosetta Genomics Ltd. (ROSG: NASDAQ)
$3.40 -0.15 | -4.23%
05/17/13 - 03:59 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -10.46M | -10.10M | -15.14M | -16.50M |
| Operating Gains/Losses | 617.00K | 16.00K | -107.00K | -19.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -77.00K | 9.00K | 51.00K | -841.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 170.00K | -2.02M | 26.00K | 302.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 11.00K | -359.00K |
| (Increase) Decrease In Other Working Capital | -722.00K | -1.60M | -978.00K | 1.70M |
| Other Non-Cash Items | 258.00K | 3.27M | 2.24M | 3.15M |
| Net Cash From Continuing Operations | -8.67M | -10.04M | -13.72M | -12.23M |
| Net Cash From Discontinued Operations | 30.00K | -1.22M | 0.00 | 458.00K |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -8.64M | -11.26M | -13.72M | -11.77M |
| Sale of Property, Plant & Equipment | 60.00K | 168.00K | 7.00K | 1.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 3.89M | 2.29M |
| Purchases of Property, Plant & Equipment | -270.00K | -11.00K | -440.00K | -199.00K |
| Acquisitions | 0.00 | 814.00K | 147.00K | -35.00K |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -1.49M | -4.50M |
| Other Cash from Investing Activities | -15.00K | 41.00K | 4.03M | -2.71M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -225.00K | -2.53M | 6.14M | -5.16M |
| Issuance of Debt | 1.75M | 0.00 | 4.00K | 823.00K |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 38.65M | 9.63M | 7.11M | 5.73M |
| Repayment of Long-Term Debt | -1.48M | -70.00K | -143.00K | -129.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 38.92M | 11.80M | 6.98M | 6.45M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 30.06M | -1.99M | -602.00K | -10.48M |
Portfolios with ROSG
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Current Portfolio
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest ROSG Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.02.13 | 02:04 pm
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- 3 Stocks Under $5 Making Big Moves 02.05.13 | 02:02 pm
- 7 Stocks Under $10 Making Large Upside Moves 11.23.12 | 12:11 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 3 Stocks Under $10 Making Big Moves 09.18.12 | 02:09 pm
- 5 Stocks Poised for Breakouts 08.24.12 | 12:08 pm
- 5 Stocks Under $10 Set to Soar 08.09.12 | 12:08 pm
- 7 Stocks Ripping Higher With Big Volume 06.26.12 | 01:06 pm
- 7 Stocks Surging on Big Volume 05.29.12 | 01:05 pm
Press Releases for ROSG
- Rosetta Genomics Receives Full Settlement Payment From Sanra Laboratories - PR Newswire 05.10.13 | 08:05 am
- Rosetta Genomics MicroRNA-based Diagnostic Assays To Be Showcased In An Industry Expert Theater Presentation At ASCO's 2013 Annual Meeting - PR Newswire 05.07.13 | 08:05 am
- Rosetta Genomics Reaches Settlement Agreement With Sanra Laboratories In Connection With Previous Sale Of Parkway Clinical Laboratories - PR Newswire 04.18.13 | 09:04 am
- Rosetta Genomics Announces Poster Presentations At AACR Annual Meeting 2013 - PR Newswire 04.02.13 | 09:04 am
- Rosetta Genomics Announces Acceptance For Publication Of Kidney Cancer MicroRNA Diagnostic Manuscript By Molecular Oncology - PR Newswire 04.01.13 | 08:04 am
- Rosetta Genomics To Host Business Update Conference Call On April 10, 2013 - PR Newswire 03.25.13 | 08:03 am
- Rosetta Genomics To Be Featured On The Balancing Act® Airing On Lifetime Television Network - PR Newswire 01.30.13 | 09:01 am
- Rosetta Genomics And Precision Therapeutics Announce U.S. Commercial Launch Of MiRview® Mets2 - PR Newswire 10.02.12 | 08:10 am
- Rosetta Genomics Names Brian Markison Board Chairman - PR Newswire 04.12.11 | 07:04 am
- Rosetta Genomics To Raise $6.0 Million In Concurrent Private Placement And Registered Direct Offerings - Business Wire 02.17.11 | 09:02 am
Partner Headlines for ROSG
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- Rosetta Genomics Expands Management Team With CMO and CSO - Benzinga 10.11.12 | 09:10 am
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 09.18.12 | 09:09 am
- Healthcare Biz Recap: Amylin in FDA HOT WATER, Rosetta Genomics OFFERS Up Shares - Wall St. Cheat Sheet 06.26.12 | 10:06 am
- Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics - Benzinga 06.01.12 | 01:06 pm
- Rosetta Genomics and 3 NASDAQ Top Percentage Losing Stocks - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Rosetta Genomics and 2 NASDAQ Top Percentage Losers - Wall St. Cheat Sheet 05.29.12 | 09:05 am
